STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

Protecting people against Covid infection ... The FDA later backed the vaccine panel, authorizing a new formulation of the booster shots. The updated vaccine, called a bivalent, targets the ...

That data suggested the possibility that the updated booster might not be any more effective at preventing Covid ... the FDA advisers’ meeting, the agency authorized the Moderna bivalent vaccines.

This safety concern has not been identified with Moderna's (MRNA.O) bivalent shot and both the CDC and FDA continue to recommend ... EU may pay more for Pfizer COVID shots in return for lower ...

Pfizer/BioNtech and Moderna's bivalent shots ... Both the CDC and FDA continue to recommend that everyone aged six months and older stay up-to-date with their COVID-19 vaccination, despite ...

A vaccine safety monitoring system detected a "safety signal" that Pfizer's bivalent booster ... and older stay up to date on their COVID-19 shots. The FDA's Vaccines and Related Biological ...

The FDA also "asked its panel of external advisers to consider the usage of two COVID vaccine shots a year for some ... "we fully expect that the updated bivalent vaccines containing BA.